Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenytoin in acute optic neuritis
NCT02939937Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in optic neuritis (ON) comparing Phenytoin with Placebo (2 arms). Primary endpoints: Retinal Ganglion Cell Inner Plexiform Layer Thickness at 6 months, Macular Layer Thickness at 6 months and 2 more. Started Mar 2017; status: completed.
02
Drugs
phenytoin
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT02939937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02939937.